Key result
Routine reimbursement maintains high patient satisfaction with Satelia Cardio remote monitoring comparable to trial levels.
Why the study?
Following the transition of remote monitoring for chronic heart failure from an experimental programme to routine reimbursement in France, whether patient-reported experience remained similar was unknown.
Does patient-reported experience of digital remote monitoring for chronic heart failure differ between experimental and routine reimbursement periods?
Cross-Sectional (n=1,378)
Does patient-reported experience of digital remote monitoring for chronic heart failure differ between experimental and routine reimbursement periods?
Patient-reported satisfaction with digital remote monitoring for chronic heart failure remained high during routine implementation, though usability challenges were noted in patients aged ≥80 years.
Sustained high satisfaction supports routine remote HF monitoring; extends experimental data but leaves open age-related usability optimization.
Background/Objectives: In France, remote monitoring for chronic heart failure transitioned from the experimental ETAPES programme (Expérimentations de télémédecine pour l’amélioration des parcours de santé) to routine reimbursement in July 2023. Whether patient-reported experience remained similar during routine implementation in a real-world respondent population was unknown. This study compared satisfaction, usability, and perceived benefits among Satelia® Cardio users surveyed in 2020–2021 and 2024. Methods: This repeated cross-sectional study compared 978 adult users surveyed between August and December 2024 with 400 digitally literate users from the 2020–2021 reference cohort. Ten comparable items were analysed as the proportion selecting scores of 7–10. Differences were assessed using Pearson’s chi-square test with Yates’ continuity correction. Exploratory age-stratified analyses examined three usability items. Results: In 2024, 30.1% of respondents were aged ≥80 years. Overall satisfaction was similar (80.3% vs. 77.0%; p = 0.20). Two perception items showed higher unadjusted ratings: perceived improvement in treatment adherence (60.1% vs. 52.3%; +7.9 percentage points; p = 0.009) and perceived help to the treating physician (76.5% vs. 70.3%; +6.2 percentage points; p = 0.019); however, these findings remained exploratory after correction for multiplicity. Usability ratings were slightly lower in 2024, with the largest differences versus the aggregate 2021 reference among respondents aged ≥80 years; ratings among those aged <70 years were similar to 2021 values. The recommendation rate to other patients was high at 70.3%. The three most frequently reported perceptions of Satelia® Cardio were that telemonitoring was reassuring, useful and simple. Conclusions: During the routine-reimbursement period, satisfaction remained high in a respondent population in which 30.1% were aged ≥80 years. Two perception items showed higher unadjusted ratings, but these findings remained exploratory after correction for multiplicity. Descriptively lower usability ratings in the ≥80-year stratum warrant further evaluation and tailored support. Because the surveys involved independent, differently composed samples, causal and longitudinal conclusions cannot be drawn. These findings describe patient experience across two successive implementation contexts and should not be interpreted as evidence of a causal effect of reimbursement policy.
No takes yet. Share an insight, caveat, or question.
Jourdain et al. (2026) conducted a cross-sectional in Chronic heart failure (n=1,378). Satelia Cardio digital remote monitoring program (routine reimbursement period 2024) vs. Satelia Cardio digital remote monitoring program (experimental ETAPES period 2020-2021) was evaluated on Overall satisfaction (proportion selecting scores of 7-10) (+3.3 percentage points, p=0.20). Overall satisfaction with the Satelia Cardio remote monitoring program remained high and similar between the routine reimbursement period and the experimental period (80.3% vs. 77.0%, p=0.20).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: